A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET imaging following intravenous administration of AH111585 (18F) Injection
A Phase IV, open-label, non-randomized, multicenter study to evaluate safety and efficacy of intravenous administration of Sonazoid™ for contrast-enhanced ultrasound liver imaging in paediatric patients
A single-arm, multicentre, Post-marketing observational follow up on patients who have been given Gadolinium for clinical scans to detect all prospective adverse events immediately post dose and 6 (±2) weeks after administration of Omniscan
100 项与 GE Healthcare AG 相关的临床结果
0 项与 GE Healthcare AG 相关的专利(医药)
100 项与 GE Healthcare AG 相关的药物交易
100 项与 GE Healthcare AG 相关的转化医学